Aclarion Inc. (ACON)
NASDAQ · Healthcare
Aclarion Inc. EBITDA 2021–2025
Aclarion Inc. annual/quarterly ebitda history and growth rate from 2021 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Aclarion Inc. ebitda for the quarter ending March 31, 2026 was -2.9 M, a 103.66% increase year-over-year.
- Aclarion Inc. ebitda for the twelve months ending March 31, 2026 was -6.7 M.
- Aclarion Inc. annual ebitda for 2025 was -6.8 M, a 28.29% increase from 2024.
- Aclarion Inc. annual ebitda for 2024 was -5.3 M, a 12.87% increase from 2023.
- Aclarion Inc. annual ebitda for 2023 was -4.7 M, a 13.01% decrease from 2022.
- Aclarion Inc. annual ebitda for 2022 was -5.4 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aclarion Inc. EBITDA — FAQ
Aclarion Inc. (ACON) ebitda over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ACON's ebitda history?
The chart and table above show Aclarion Inc.'s ebitda by year and by quarter, including the growth rate.